PHA
515: Drug Information Rotation
Center for Drug Information & Evidence-Based Practice
Creighton University
Table of Contents:
1.
The first day
2.
What we do and do NOT do
3.
Hours of
operation & Rules of the Center
4.
Contact information
5.
Preceptors
6.
Syllabus & Grading
7.
Student Responsibilities
8.
Getting set up
9.
Introduction to receiving questions
10.
Monographs & Class
Reviews for P&T
11.
DUEs for P&T
12.
Drug Info Lunch Date
Presentations
13.
Journal Club
14.
Newsletter
15.
Appendix 1: Monographs and Class Reviews
16.
Appendix 2:
DUEs
17.
Appendix 3:
Selected tertiary resources
18. Appendix
4: AHFS on Excel
The first day
<Back to top>
You should
arrive at 10 am on the first morning of clerkship. You
will need your laptop, lab coat and name tag. The first day
will consist of orientation to the clerkship, computer set up,
and a
literature searching refresher course.
The first 2-3 afternoons of this rotation
will involve a training class in conjunction with the library
reference staff. This takes
place from 330pm until 5pm. This is a very helpful class to
re-familiarize you with searching the literature.
Drug information
questions come in at all times, so be prepared to start
answering questions on the first day.
What we do
and do NOT do
<Back to top>
We
do…
-
Take questions from health professionals primarily regarding
drugs and drug therapy.
-
Receive requests primarily from phone calls, but also
through email and fax.
-
Receive questions on a very broad range of topics including
dietary supplements, lab test monitoring, disease
management, manufacturer information, etc.
-
Provide support to CUMC P&T committee.
-
Assist P4 students on clerkship, provided the preceptor is
involved.
We
do NOT…
-
Take calls from the general public.
-
Work on assignments for pharmacy or other health professions
students. If a student asks you to help with a project,
contact your preceptor before doing so.
-
Serve as an article retrieval or copy service. If callers
just want a copy of an article, refer them to the library
reference desk. If it is a faculty member asking, talk
to one of the DI preceptors.
Hours
of Operation & Rules of the Center
<Back to top>
The
Center is open every business day Monday thru Friday from
830 am to 430 pm.
Although the start time is 10 am on the first day, everyday
thereafter the start time will be at 830 am.
-
Dress: professional dress
(minimum of business casual) is required.
-
Visitors: Visitors are
permitted, but be courteous to your fellow classmates. If
you are going to have an extended conversation with a
visitor, please go outside the Center.
-
Food and drink: Permitted within
reason.
Contact
information
<Back to top>
Voice: 280-5100 or
280-5101
Toll-Free:
800-561-3728
Fax: 280-5149
Primary
Preceptors
HSL Rotation
<Back to top>
Philip Gregory, PharmD,
Coordinator, Drug Information Residency
Office: 280-5118
Pager: 978-0081
Zara Risoldi Cochrane, PharmD,
Drug Information Specialist
Office:
280-5161
Pager: 978-0149
Amy Wilson, PharmD,
Director, Center for Drug Information & Evidence-Based Practice
Office: 280-3269
Pager: 978-157
CUMC
Rotation
Anne Bruckner,
BS, PharmD, Drug Information Specialist
Office:
280-5158
Pager:
978-1223
All preceptors will be involved in
evaluating your rotation experience.
Syllabus & Grading
<Back to top>
To review the
syllabus and grading,
click here.
Student
Responsibilities
<Back to top>
Your primary
responsibility while on drug information clerkship is answering
drug information questions. Answering these questions should
come before any other projects or assignments. Therefore,
if you have any pending question to answer, please complete that
question before working on a project.
In addition to
questions, you will have various projects as described in this
manual.
You are expected to
approach this work with a professional attitude and make every
attempt to produce high-quality work. Everything done in
the Center will be used on a professional level. Remember
that there is a patient on the other end of everything you do.
As a courtesy to your
colleagues, please be on time. If the phone rings, answer it.
Do not wait for your colleagues to answer it for you.
The Center is
sometimes very busy. Other times it can be slow. If it is
slow and you are caught up on your assignments, be professional
and ask your colleague if you can help them out.
Alternatively, ask a preceptor if there are any other projects
you can help out with.
Playing computer
games, reading leisure books, chit-chatting, inappropriate web
surfing, or otherwise
wasting time is unprofessional and should be avoided.
We encourage you and
expect you to make the most of your experience while you are
here.
Getting set up
<Back to top>
You will need to set
up your laptop to print and to get access to the Drug
Information Question Database. We will help you set this up on
the first. Here are some instructions to get started:
Installing the printer:
Left click on start, select run, in the box type
\\spahpprint , click OK, it will search and then show a list
of printers, select the DICsavin2522 and double click on it,
once the printer has been installed set it as the default.
Accessing the Drug Information Database:
All consultation requests and responses
must be documented in the Drug Information Database.
Get detailed instructions on using this database.
Introduction to receiving & answering questions
<Back to top>
We
receive questions most often by phone, but also by email and
fax.
How to answer the phone
“Creighton Drug Information Service, this is xxxxxxx” or
something similar. Please always state your name so the caller
knows who they are talking to.
When you receive a question
·
Make sure you get adequate background information
in order to determine the ultimate question. If you don’t get
the background information initially, you might have to call the
requester back to clarify.
·
Fill out the information request form and
immediately enter into the database.
·
Think about and write down your search
methodology.
·
Consult with the preceptor to let them know you
have received a new question BEFORE starting to research your
question.
Before you answer a question
·
Discuss your response with the preceptor. The
preceptor must “sign off” on your response before you give ANY
answer. This applies even to simple tablet identification
questions. Failure to check with the preceptor BEFORE
responding to any question is grounds for failure of this
rotation.
·
EVERYTHING must be
documented in your response in the DI database. We need to know all of the
background of the question (even if you think it is
unimportant), where you looked (even if you didn't find anything
there), and details of your proposed response, whether it is to
be written or discussed verbally.
Written Responses to Questions (i.e., Formal Response)
·
All written responses must be in the proper memo
format. Question examples are available in the DI database
for your review (see links below)
·
All responses must be properly formatted including
an introduction, methodology, results, and conclusion. All responses must
be written clearly, concisely, and appropriately to answer the
question. This means good grammar, no misspellings, etc.
Do not ask your preceptor to review a document that you have not
already thoroughly proofed and corrected for spelling and
grammar.
·
All responses must be properly referenced using
the reference format from the literature evaluation course
(i.e., AMA style).
·
If you have any questions, ask a preceptor BEFORE
your start.
Document your responses
·
All responses, written and verbal must be documented in the Drug
Information Database. This must occur before the
question is sent out. All responses must be documented
using the standard format described in the template (intro,
methodology, results, conclusion, recommendations). This must be done for both
written and verbal responses.
Emails
·
Any email communications with users of the DI
service, must be courteous and in written in a letter-like
format. This means that you address the email (e.g., start with
Dr. Abc) and signed (e.g., Sincerely, Ed Pharmacist, PharmD
Candidate).
·
All emails should have a subject line include.
Phone Calls/Fax
·
A special code is needed to make long-distance
phone calls. Just ask the preceptor to enter the code when you
need to make a long-distance call.
·
Personal calls using the phones or fax in the DIC
are not permitted. You can take personal calls on your own cell
phone, just be courteous to your fellow classmates.
Confidentiality
The
questions you receive are considered confidential. Do not share
with others outside of the drug information clerkship. This is
private information to be shared only between you, the caller,
and the preceptor.
Lawyers and Media
Occasionally we get calls from lawyers or media or other people
wanting quotes or research for legal cases, etc. In the event
that you receive a call like this, find your preceptor or take a
message and the preceptor will call the person back.
Monographs
& Class Reviews for P&T
<Back to top>
Students may be involved in developing a monograph or class
review for the CUMC or Childrens Hospital P&T Committee.
Monographs and class reviews follow a similar format, but
monographs only cover one drug in a class. Class reviews compare
and contrast all drugs in a class.
This format may be modified for specific reasons. Ask your
preceptor before making any formatting changes.
Students completing a monograph or class review may
present their monograph or class review at the P&T committee.
Your preceptor will let you know the day and time.
See
Appendix 1 for a sample monograph and class review from CUMC.
Drug Use Evaluations
During
the rotation, all students will be responsible for assisting in
data collection for an ongoing quality project at CUMC.
This Drug Use Evaluation (DUE) will allow practitioners
responsible for quality initiatives at the hosptial to review
data and make evidence-based decisions about policy and
procedures. During the first week of the rotation, you
will receive background information on the project you will be
involved with, as well as technical training for data searching
and retrieval. Appendix 2 below contains examples of DUE
data and results.
<Back to top>
Drug
Info Lunch Date Presentations
<Back to top>
All students on the
HSL Drug Information Rotation will have the opportunity to
present one of their drug information consultations at a "Drug
Info Lunch Date" session. These sessions occur on Tuesdays
during weeks 4 and 5 of the rotation.
Your topic for
presentation will be selected during the first 2-weeks of the
rotation. You and your preceptor will work together to
select an appropriate topic. Topics considered appropriate
for presentation should be interesting, timely, and practical.
If you get a
consultation request that you think fits these criteria, alert
your preceptor. Topics must be selected by the end of the
second week of your rotation.
Your presentation
will be prepared using PowerPoint slides. Each
presentation will be no longer than 15 minutes long. It
should focus on the most pertinent and practical information.
Each presentation should follow the general format of a
consultation response including introduction, methodology,
results, and conclusion. Like your consultation request,
the ultimate goal is to give practitioners information that they
can use.
You will work with
your preceptor to finalize the slides for your presentation.
Journal Club
<Back to top>
Each student on drug
information rotation will present a journal club article.
For an example of how
to conduct a good journal club presentation, watch this
video. (**Note: pay attention to what
is said rather than what is shown on the screen. We have
changed the format of journal club since this video was taken).
Purpose
There are at least three goals of journal club during this
clerkship:
-
Keep up-to-date
with current literature on drug therapy.
-
Gain experience
in literature evaluation.
-
Practice
presentation skills
Responsibilities of the Presenter
·
Select an appropriate journal article to review
(see below)
o
Provide a copy of your article to each student and
faculty member at least one week before your presentation day.
·
Critically evaluate your article. Use this
evaluation tool to help identify strengths, weaknesses, and
limitations of the study.
·
Summarize your evaluation of the article in
written form (see example below). Distribute this document the
day of your presentation.
·
Present your article and your critical evaluation
orally during your selected time. Focus on providing
practical information and putting the article into context.
·
DO NOT read your hand out as your presentation.
·
Your presentation should last no longer than 15 minutes.
·
Discuss the article with your colleagues.
Responsibilities of the Participants
·
Review the article selected by the presenter ahead
of time. Come prepared to discuss.
·
Listen to the evaluation of the presenter.
·
Ask relevant questions.
·
Discuss your evaluation of the article with your
colleagues.
Criteria for Choosing your Article
·
Current – preferably something within the
last 3-6 months; nothing older than 12 months.
·
Relevant – choose articles most relevant to
our profession (i.e., drug therapy). Avoid articles that focus
on diagnostics or disease state epidemiology, etc. Ask
yourself: “Will this study impact or change my practice in any
way?” If the answer is ‘yes’ then you have a good article.
·
Try to pick a topic you
think participants will find interesting and important to them.
This makes the whole process much more fun.
Journal Club Presentation Format
<Back to top>
Citation: Enter the journal article citation
Question: State the research question or hypothesis
of the study. What is the question the authors intended to
answer by conducting the study?
Background/Introduction: In this section explain the
background of the issue the study is trying to address.
Explain why it is important to us and why we need to know about
this topic. If you have difficulty explaining why it is
important you may need to reevaluate whether you've selected an
appropriate article.
Study Overview: In this section give an overview
of the study. Focus on key information about study design and
methodology, and results. Remember, make your presentation
practical. When you discuss results make sure you include
pertinent, practical information about the treatment effect.
This include providing relative risk, absolute risk, and number
needed to treat when applicable.
Discussion: In this section, discuss the meaning
of the study. Describe what you think this study tells us and
what questions you think this study does not answer. Describe
limitations and explain how the the limitation affects our
interpretation of the findings. Finally, and most importantly,
put the study into context. Tell us how the study fits into the
big picture. Does it change our practice? If so,
explain how. Without understanding the context of findings
from new studies, we cannot apply the findings.
Newsletter
<Back to top>
Each student will be
responsible for creating a newsletter article during the
rotation. Students will work together to publish an electronic
newsletter, based on our established template, containing all
the articles. Topics for newsletter articles will be
determined the preceptor. Newsletter articles should be focused
for a professional audience, and must be fully referenced.
Following a peer-review process, the newsletter will be
distributed electronically to local, regional and national
practitioners. Click
here
for examples.
Appendix 1. Monograph & Class Review Instructions and Examples
<Back to top>
Monograph template,
click here
Sample
monographs:
Micafungin,
Daptomycin
Appendix 2.
DUE instructions and examples
<Back to top>
To see a sample of
DUE criteria/Data collection sheet,
click here.
To see a sample of a completed DUE,
click here.
Appendix 3: Select Tertiary Resources
<Back to top>
ADVERSE REACTIONS AND SIDE EFFECTS
Major References
Meyler's Side Effects of Drugs
American Hospital Formulary Service (AHFS) Drug Information
Facts and Comparisons
Martindale's Extra Pharmacopoeia
Physician's Desk Reference (PDR)
Textbook of Adverse Drug Reactions (Davies)
U.S. Pharmacopeial Dispensing Information (USP-DI)
Drugdex
AMA Drug Evaluation
Product labeling
Handbook of Poisoning
Clinical Toxicology of Commercial Products
Drug Effects in Hospitalized Patients (Miller and Greenblatt)
FDA Drug Bulletin
For Antibiotics
The Use of Antibiotics
Minor References
The Pharmacological Basis of Therapeutics (Goodman and Gilman)
Secondary References
Clin Alert
International Pharmaceutical Abstracts (IPA)
Index Medicus/Medline
Poisindex
AVAILABILITY
Major References
U.S. Availability
American Drug Index
Manufacturer
Facts and Comparisons
PharmIndex
Drug Topics Redbook PDR
Blue Book
Physician’s Generex
Drugdex
USAN and USP Dictionary
Foreign Availability
Martindale's Extra Pharmacopoeia
Index Nominum
Drugs Available Abroad
Foreign Equivalents of PDR
Minor References
Handbook of Nonprescription Drugs
Medical Letter
Facts and Comparisons Newsletter
Pharmacists Letter
CHEMICAL PROPERTIES
Major References
Merck Index
AHFS Drug Information
Martindale's Extra Pharmacopoeia
Remington's Pharmaceutical Sciences
USP-National Formulary
COST INFORMATION
Major References
Drug Topics Redbook
Blue Book
Manufacturers and wholesalers
Physician's Generix
Minor References
Facts and Comparisons
Medical Letter
DOSING AND ADMINISTRATION
Major References
AHFS Drug Information
AMA Drug Evaluations
PDR
Facts and Comparisons
USP-DI
Martindale's Extra Pharmacopoeia
Drugdex
For Pediatrics
Harriett Lane Handbook
Textbook of Pediatrics (Nelson)
Pediatric Therapy (Shirkey)
Pediatric Dosage Handbook (Taketoma, Hodding, Kraus)
For Renal Patients/Hemodialysis
Bennett's Nomogram
For Geriatrics
Geriatric Dosage Handbook (Semla, Beizer, Higbee)
DRUG INTERACTIONS
Major References
Hansten's Drug Interactions
Evaluations of Drug Interactions (Shinn)
Drug Interactions Facts
Minor References
AHFS Drug Information
Meyler's Side Effects of Drugs
Facts and Comparisons
Drugdex
AMA Drug Evaluations
Note: Also consider
additive pharmacologic properties or additive toxicities. May
need to use pharmacology, chemistry, stability, or adverse
effects references too!
DRUG IDENTIFICATION
Major References
American Drug Index
Facts and Comparisons
Drugdex
Ident-A-Drug
Poisindex
Martindale's Extra Pharmacopoeia
USAN and USP Dictionary
Merck Index
PDR
Drug Topics Redbook
Blue Book
By Imprint Code
Identidex
PDR
Pictures
PDR
USP-DI
PDR Identification Kit
IMMUNIZATION INFORMATION
Major References
Report on the Committee on Infectious Diseases
Morbidity and Mortality Weekly Report (MMWR)
CDC-Health Information for International Travel
AHFS Drug Information
Guide for Adult Immunization (ACP)
INVESTIGATIONAL DRUGS
Major References
Martindale's Extra Pharmacopoeia
Drugdex
NCI Investigational Drugs: Pharmaceutical Data
PharmIndex
Medical Subject Headings--Suppl Chemical Records
NDA Pipeline
Orphan Drugs
Drugdex
Facts and Comparisons
Treatment IND
Facts and Comparisons
AHFS Drug Information
Secondary References
Unlisted Drugs
IPA
Iowa Drug Information Service (IDIS)
Periodicals
Phase III Trials
"Pink Sheet" FDC Reports
LABORATORY INFORMATION
Major References
Interpretation of Diagnostic Tests (Wallach)
Diagnostics
Clinical Interpretation of Laboratory Tests (Wiomann)
Clinical Diagnosis by Laboratory Methods
Clinical Laboratory Medicine (Ravel)
For Lab/Drug Interactions
Effects of Drugs on Clinical Laboratory Tests (Young)
Hansten's Drug Interactions
AMA Drug Evaluations
AHFS Drug Information
For Antibiotics
Use of Antibiotics in Laboratory Medicine (Lorian)
LAWS AND REGULATIONS
Major References
State and Federal Law
State Pharmacy Practice Act
State Board of Pharmacy Regulations
Pharmacy Law Digest
Code of Federal Regulations
Pharmacy Law Texts
Federal Register
MANUFACTURER'S ADDRESSES AND PHONE NUMBERS
Major References
PDR
Facts and Comparisons
Poisindex
Clinical Toxicology of Commercial Products
Martindale's Extra Pharmacopoeia
Minor References
American Drug Index (addresses only)
NATURAL PRODUCTS
Major References
Integrative
Medicine Access
Martindale's
Extra Pharmacopoeia
Natural
Medicines Comprehensive Database
PDR for Herbal
Medicines
Poisindex
Professional's
Handbook of Complementary and Alternative Medicine
Review of
Natural Products
PATIENT INFORMATION
Major References
USP-DI Volume II: Advice for the Patient
Patient Drug Facts
PHARMACOKINETICS
Major References
Applied Pharmacokinetics (Evans, Schentag, Jusko)
Drugdex
AHFS Drug Information
Basic Clinical Pharmacokinetics (Winters)
Applied Clinical Pharmacokinetics (Mungall)
USP DI Volume III
Minor References
Goodman and Gilman
PDR
Handbook of Clinical Drug Data
Martindale's Extra Pharmacopoeia
PHARMACOLOGY
Major References
Goodman and Gilman
Clinical Pharmacology (Melmon and Morrelli)
AHFS Drug Information
Minor References
PDR
POISONING/TOXICOLOGY
Major References
Poisindex
Clinical Toxicology of Commercial Products
Clinical Management of Poisoning and Drug Overdose (Haddad,
Winchester)
Handbook of Poisoning (Dreisbach)
Poisoning-Toxicology-Symptoms-Treatments
Montana Poison Control Center 1-800-525-5042
Minor References
AHFS Drug Information
PREGNANCY AND LACTATION
Major References
Drugs in Pregnancy and Lactation (Briggs)
AHFS Drug Information
USP-DI
PDR
Pediatrics 1989;84:924-36
Handbook of Clinical Drug Data
Drugdex
Drug Therapy in Obstetrics and Gynecology (Rayburn)
Drugs and Human Lactation (PN Bennett and WHO Working Group)
Clinical Aspects of Teratogenicity of Drugs (Nishimura, Tanimura)
STABILITY/INCOMPATIBILITY
Major References
Handbook on Injectable Drugs (Trissels)
Guide to Parenteral Admixtures (also called Kings or Cutter
Manual)
AHFS Drug Information
Drugdex
Manufacturer
Secondary References
IPA
THERAPEUTIC USE OF DRUGS
Major Medical References
Practical Care for the Ambulatory Patient (Stultz, et al)
Manual of Medical Therapeutics (Washington Manual)
Textbook of Medicine (Cecil)
Harrison's Principles of Internal Medicine
Harvey's The Principles and Practice of Medicine
Current Therapy (Conn)
Merck Manual of Diagnosis and Therapy (Berkow)
The Pathologic Basis of Disease (Robbins)
Pharmacy Therapeutic Texts
Applied Therapeutics for Clinical Pharmacists (Koda-Kimble)
Clinical Pharmacy and Therapeutics (Herfindel, et al)
Pharmacotherapy. A Pathophysiological Approach (DiPiro)
AHFS Drug Information
Martindale's Extra Pharmacopoeia
AMA Drug Evaluations
Drugdex
Handbook of Nonprescription Drugs
For Antibiotics or Infectious Disease
The Use of Antibiotics
A Practical Approach to Infectious Diseases (Reese RE, Betts RF)
Guide to Antimicrobial Therapy (Sanford)
Appendix
4: AHFS on Excel
Students will help
with the AHFS classification review process required by JCAHO @
CUMC.
|